期刊文献+

PI3K p85α蛋白表达缺失联合5-FU对大肠癌细胞的促凋亡作用 被引量:1

The proapoptotic effect of combination PI3K p85α depletion and 5-FU treatment on colorectal cancer cells
下载PDF
导出
摘要 探讨RNA干扰靶向抑制PI3K p85α蛋白表达联合5-FU对大肠癌LoVo细胞的促凋亡作用。方法复苏培养PI3K p85α干扰组LoVo细胞(PI3Kp85ɑ/RNAi-LoVo)和LoVo对照组细胞,Western blot鉴定干扰效果,MTT法检测5-FU对两组细胞的半数抑制浓度(IC50),Annexin-FITC标记法检测细胞凋亡。结果 Western blot结果显示LoVo干扰组细胞PI3K p85α蛋白抑制率为59%,MTT结果显示干扰组细胞5-FU的IC50值(4.57±0.16)μmol/L明显低于对照组细胞5-FU的IC50值(8.07±0.30)μmol/L(P=0.000),细胞凋亡实验显示,干扰组细胞对5-FU诱导凋亡的敏感性增加(P=0.000)。结论 PI3K p85α蛋白表达缺失联合5-FU可促进大肠癌LoVo细胞凋亡,为基因治疗和化学药物联合治疗大肠癌提供新的策略。 Objective To investigate the proapoptotic effect of combination PI3K p85α depletion via RNA interference and 5-FU treatment on colorectal cancer cells. MethodsPI3K p85α/RNAi-LoVo cells and LoVo control cells were recovered and cultured in RPMI1640,supplemented with 10% fetal calf serum and 500 μg/mL G418.Western blot analysis was used to determine the RNA interference effect.The 50% inhibitory concentration(IC50) value of 5-FU was evaluated by MTT assay.Annexin V-FITC Kit was used to determine the apoptosis. ResultsWestern blot analysis showed that the inhibited rate of PI3K p85α protein was 59%.Compared with the control cells,IC50 of 5-FU in PI3K p85α/RNAi-LoVo cells obviously decreased(P=0.000).Depletion of PI3K p85α sensitized LoVo cells to 5-FU induced apoptosis(P=0.000). ConclusionCombination PI3K p85α depletion and 5-FU treatment could promote apoptosis of LoVo cells.It may be a new therapeutic strategy for gene therapy and chemotherapy of colorectal cancer.
出处 《胃肠病学和肝病学杂志》 CAS 2011年第3期212-215,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 大肠癌 磷脂酰肌醇3-激酶p85α亚单位 RNA干扰 细胞凋亡 5-氟脲嘧啶 Colorectal cancer PI3K p85α RNA interference Apoptosis 5-fluorouracil
  • 相关文献

参考文献13

  • 1Hong YS, Kim TW. Chemotherapy for colorectal cancer [ J]. Korean J Gastroenterol, 2009, 54 (6): 355-363.
  • 2Falasca M. PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs [ J]. Curr Pharm Des, 2010, 16 (12): 1410-1416.
  • 3孙嫣,田华,肖法嫚,谢晓云,宋于刚.PI3K p85α在大肠癌癌变过程中的表达及意义[J].南方医科大学学报,2009,29(3):416-418. 被引量:14
  • 4孙嫣,田华,谢晓云,肖法嫚,宋于刚.RNA干扰靶向抑制PI3Kp85α蛋白对大肠癌细胞增值的影响[J].数理医药学杂志,2009,22(3):274-277. 被引量:1
  • 5Ahn S, Kim J, Hara MR, et al.{ beta} -Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation [J]. J Biol Chem, 2009, 284 (13): 8855-8865.
  • 6del Peso L, Gonzalez-Garcia M, Page C, et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt [ J]. Science, 1997, 278 (5338) : 687-689.
  • 7Sarker D, Reid AH, Yap TA, et al. Targeting the PI3K/AKT pathway for the treatment of prostate cancer [ J]. Clin Cancer Res, 2009, 15 (15) : 4799-4805.
  • 8Nicholson KM, Anderson NG. The protein kinase B/Akt signaling pathway in human malignancy [J]. Cell Signal, 2002, 14 (5) : 381- 395.
  • 9Jiang JX, Mikami K, Venugopal S, et al. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways [ J]. J Hepatol, 2009, 51 ( 1 ) : 139-148.
  • 10Lauder A, Castellanos A, Weston K. c-Myb transcription is activated by protein kinase B ( PKB ) following interleukin 2 stimulationof T cell and is required for PKB-mediated protein from apoptosis [ J]. Mol Cell Biol, 2001, 21(49): 5797-5805.

二级参考文献40

  • 1胡蕾,姜汉国.PI3K/AKT信号转导通路与肿瘤转移及其机制的研究进展[J].医学综述,2006,12(22):1375-1377. 被引量:18
  • 2Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: Its functions and alterations in human cancer [J].Apoptosis, 2004, 9 (6): 667-76.
  • 3Carter JH, Douglass LE, Deddens JA, et al. Pak-1 expression increases with progression of colorectal carcinomas to metastasis [J]. Clin Cancer Res, 2004, 10 (10): 3448-56.
  • 4Dong Z, Huang C, Ma WY. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer [J]. Anticancer Res, 2001, 19 (5A): 3743-7.
  • 5Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy[J]. Leukemia, 2003, 17 (3): 590-603.
  • 6Jimenez C, Jones DR, Rodriguez-Viciana P, et al. Identification and characterization of a new oneogene derived from the regulatory subunit ofphosphoinositide 3-kinase[J]. EMBO J, 1998, 17 (3): 743-53.
  • 7Philp AJ, Campbell IG, Leet C, et al. The phosphatidylinositol 3'-kinase p85 alpha gene is an oncogene in human ovarian and colon tumors[J]. Cancer Res, 2001, 61 (20): 7426-9.
  • 8Lee SH, Kim HS, Park WS, et al. Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistuchemical study [J]. APMIS, 2002, 110 (7-8): 587-92.
  • 9Itoh N, Semba S, Ito M, et al, Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma[J]. Cancer, 2002, 94 (12): 3127-34.
  • 10Shukla S, Maclennan GT, Marengo SR, et al. Constitutive activation of PI3K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model[J]. Prostate, 2005, 64 (3): 224-39.

共引文献13

同被引文献10

  • 1Sheppard K, Kinross K M, Solomon B, et al. Targeting PI3kinase/AKT/mTOR signaling in cancer [J].Crit Rev Oncog, 2012,17( 1 ) : 69-95.
  • 2Wu P, Hu Y Z. PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress [J]. Curr Med Chem, 2010, 17(35) :4326-4341.
  • 3Arboleda M, Lyons J F, Kabbinavar F F, et al. Overexpression of AKT2/protein kinase Bbeta leads to up- regulation of betal integrins,increased invasion, and metastasis of hunlan breast and ovarian cancer cells [J]. Cancer Res, 2003,63( 1 ) : 196-206.
  • 4Virtakoivu R, Pellinen T, Rantala J K, et al. Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer [J]. Mol Biol Cell, 2012, 23(17): 3357-3369.
  • 5Thiel A, Heinonen M, Rintahaka I, et al. Expression of cyclooxygenase-2 is regulated by GSK-3beta in gastric cancer cells [J]. J Biol Chem, 2006, 281(8):4564-4569.
  • 6Hildenbrand R, Schaaf A. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion [J]. Int J Oncol, 2009, 34(1 ) : 15-23.
  • 7Fu Y, Zhang Q, Kang C, et al. Inhibitory effects of adenovirus mediated Aktl and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo [J]. Cancer Biol Ther, 2009, 8( 11 ) : 1002-1009.
  • 8王艳丽,高青.抑制PI3K/Akt信号通路对胃癌细胞转移和侵袭影响的研究[J].重庆医科大学学报,2011,36(1):27-30. 被引量:8
  • 9张勇,陈腾.PI3K/AKT信号通路与结肠直肠癌关系的研究进展[J].外科理论与实践,2012,17(2):187-190. 被引量:4
  • 10陈彩云,刘亚京,牛忠英.慢病毒载体的研究进展及应用[J].口腔颌面修复学杂志,2012,13(2):117-120. 被引量:10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部